中文名称：5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺

英文名称：5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺

SMILES：O=C(C1=C(O[C@@H](C2=CC=CC=C2C(F)(F)F)C)C=C(N3C4=CC(CN5CCN(C)CC5)=CC=C4N=C3)S1)N

MDL：MFCD12755419

中文同义名：

5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺; GSK461364; 5-[6-[(4-甲基-1-哌嗪基)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩甲酰胺; GSK461364, 一种有效的 POLO-LIKE KINASE 1 抑制剂;

英文同义名：

5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide; GSK-461364; (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide; GSK-461364A; GSK461364(GSK-461364); 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]; GSK4613; 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phen;